NASDAQ:KRYS

Krystal Biotech Stock Insider Trading

etoro logo Buy KRYS
*Your capital is at risk
$301.82
+8.61 (+2.94%)
At Close: Jun 03, 2026

Krystal Biotech Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -37.44. In total, the insiders bought 553.96K and sold 188.03K KRYS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-37.44
Buy 553.96K shares
Sell 188.03K shares
44% Buy Activity
Negligible or No Correlation
Buy Signal Low Confidence
Feb 27, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -37.44.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Feb 27, 2026
Sell
Common Stock
F-InKind
Krishnan Suma
President, R&d
CEO / President 10 236
Value: $2.82M
Feb 27, 2026
Sell
Common Stock
F-InKind
Krishnan Suma
President, R&d
CEO / President 1 820
Value: $501.7K
Feb 27, 2026
Buy
Common Stock
M-Exempt
Krishnan Suma
President, R&d
CEO / President 4 000
Value: $1.10M
Feb 27, 2026
Buy
Common Stock
M-Exempt
Krishnan Suma
President, R&d
CEO / President 22 500
Value: $6.20M
Feb 27, 2026
Sell
Common Stock
F-InKind
Krishnan Suma
President, R&d
CEO / President 3 981
Value: $1.10M
Feb 27, 2026
Buy
Common Stock
M-Exempt
Krishnan Suma
President, R&d
CEO / President 8 750
Value: $2.41M
Feb 27, 2026
Buy
Common Stock
M-Exempt
Krishnan Krish S
President And CEO
CEO / President 4 000
Value: $1.10M
Feb 27, 2026
Sell
Common Stock
F-InKind
Krishnan Krish S
President And CEO
CEO / President 1 820
Value: $501.7K
Feb 27, 2026
Sell
Common Stock
F-InKind
Krishnan Krish S
President And CEO
CEO / President 10 236
Value: $2.82M
Feb 27, 2026
Buy
Stock Option (Right to Buy)
A-Award
Krishnan Krish S
President And CEO
CEO / President 45 249
Value: $12.5M
Feb 27, 2026
Buy
Restricted Stock Units
A-Award
Krishnan Krish S
President And CEO
CEO / President 18 140
Value: $5.00M
Feb 27, 2026
Buy
Restricted Stock Units
M-Exempt
Krishnan Krish S
President And CEO
CEO / President 5 725
Value: $1.58M
Feb 27, 2026
Buy
Restricted Stock Units
M-Exempt
Krishnan Krish S
President And CEO
CEO / President 8 750
Value: $2.41M
Feb 27, 2026
Buy
Common Stock
M-Exempt
Romano Kathryn
Chief Accounting Officer
Officer 7 500
Value: $2.07M
Feb 27, 2026
Buy
Common Stock
M-Exempt
Romano Kathryn
Chief Accounting Officer
Officer 550
Value: $151.6K
Feb 27, 2026
Sell
Common Stock
F-InKind
Romano Kathryn
Chief Accounting Officer
Officer 240
Value: $66.2K
Feb 27, 2026
Sell
Common Stock
F-InKind
Romano Kathryn
Chief Accounting Officer
Officer 3 262
Value: $899.1K
Feb 27, 2026
Buy
Stock Option (Right to Buy)
A-Award
Romano Kathryn
Chief Accounting Officer
Officer 13 575
Value: $3.74M
Feb 27, 2026
Buy
Restricted Stock Units
A-Award
Romano Kathryn
Chief Accounting Officer
Officer 5 442
Value: $1.50M
Feb 27, 2026
Buy
Restricted Stock Units
M-Exempt
Romano Kathryn
Chief Accounting Officer
Officer 550
Value: $151.6K
Feb 27, 2026
Buy
Performance Stock Units
M-Exempt
Romano Kathryn
Chief Accounting Officer
Officer 7 500
Value: $2.07M
Feb 27, 2026
Buy
Common Stock
M-Exempt
Krishnan Suma
President, R&d
CEO / President 26 250
Value: $7.24M
Feb 27, 2026
Buy
Common Stock
M-Exempt
Krishnan Suma
President, R&d
CEO / President 5 725
Value: $1.58M
Feb 27, 2026
Sell
Common Stock
S-Sale
Janney Daniel
Director
Director 2 373
Value: $655.3K
Feb 27, 2026
Sell
Common Stock
S-Sale
Janney Daniel
Director
Director 9 430
Value: $2.60M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT KRYSTAL BIOTECH INC
Krystal Biotech
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive con...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE